Wade MR: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) Β |
||
(5 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
|lastname=Wade | |lastname=Wade | ||
|firstname=Mark | |firstname=Mark | ||
|institution=Eli Lilly and Co. | |||
Lilly Corporate Center/DC0545 | |||
|address=893 S Deleware | |||
|area code=46285 | |||
|city=Indianapolis | |city=Indianapolis | ||
|state=Indiana (IN) | |state=Indiana (IN) | ||
Line 7: | Line 12: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson | ||
Β | |field of research=Pharmacological | ||
== Participated at== | }} | ||
* [[IOC104]] | == Participated at == | ||
::::* [[MiPNet20.05 IOC104 Greenville |IOC104 Greenville NC US]] | |||
::::* [[MiPNet19.06 IOC91 Philadelphia US |IOC91 Philadelphia US]] |
Latest revision as of 11:09, 14 February 2018
Name | Wade Mark, |
---|---|
Institution | Eli Lilly and Co.
Lilly Corporate Center/DC0545 |
Address | 893 S Deleware, 46285 |
City | Indianapolis |
State/Province | Indiana (IN) |
Country | USA |
[email protected] | |
Weblink | |
O2k-Network Lab | US IN Indianapolis Brozinick JT |
Labels:
Field of research: Pharmacological
Publications
Add references to your publications